Novo Nordisk has partnered with OpenAI to accelerate drug discovery and development using artificial intelligence, as pharmaceutical companies increasingly turn to AI to improve efficiency and outcomes. The collaboration will focus on analyzing complex biological datasets, identifying potential treatments, and shortening the timeline from early research to patient use. Shares of Novo Nordisk rose about 2.8% following the announcement.

The partnership aims to apply AI to some of the most resource-intensive stages of drug development. By leveraging advanced models, Novo Nordisk expects to uncover patterns in large datasets that would be difficult to detect using traditional methods. This could help researchers identify promising drug candidates earlier and test hypotheses more quickly. The company said the approach could ultimately lead to faster development of treatments, particularly for conditions such as obesity and diabetes, where demand remains high.

For OpenAI, the deal represents a further expansion into the life sciences sector, where AI is increasingly being used to support research, clinical trials, and operational workflows. CEO Sam Altman said the technology has the potential to transform industries by enabling new discoveries and improving health outcomes.

AI’s Growing Role in Pharma

The partnership reflects a broader industry trend. Drugmakers are exploring how AI can streamline processes that traditionally take years and cost billions of dollars. While fully AI-driven drug discovery remains an emerging field, companies are already seeing benefits in areas such as clinical trial design, patient recruitment, and data analysis.

Momentum is building across the sector. Eli Lilly recently signed a $2.75 billion deal with Insilico Medicine to commercialize AI-developed therapies globally, underscoring how major pharmaceutical players are investing heavily in AI-driven pipelines. In parallel, AstraZeneca has entered a $555 million milestone-based partnership with Algen Biotechnologies to combine AI with CRISPR gene-editing for immunology drug discovery. Together, these deals illustrate how AI is moving from experimental use into core R&D and commercialization strategies.

Competing in a High-Stakes Market

Novo Nordisk’s investment in AI comes as it faces intense competition from Eli Lilly in the fast-growing weight loss and diabetes treatment market. The company has been working to strengthen its pipeline with new therapies, including next-generation drugs and alternative formulations.

The partnership also builds on Novo Nordisk’s existing AI initiatives. The company has previously collaborated with Nvidia to leverage high-performance computing infrastructure for drug discovery, including the use of the Gefion supercomputer to develop customized AI models.

By combining its pharmaceutical expertise with OpenAI’s technology, Novo Nordisk is aiming to gain an edge in both innovation speed and treatment development. As AI adoption accelerates across the healthcare sector, such partnerships are likely to become a key differentiator in the race to bring new therapies to market.

Alibaba’s open-source AI video model, HappyHorse-1.0, has surged to the top of global performance rankings, outperforming leading proprietary systems and shaking up the rapidly evolving video generation market. The model now leads the Artificial Analysis Video Arena leaderboard in multiple categories, surpassing ByteDance’s Seedance 2.0 by a significant margin in blind user evaluations.

HappyHorse-1.0 achieved between 1333 and 1357 Elo points in text-to-video generation, beating its closest competitor by nearly 60 points. It also set a new record in image-to-video tasks with scores exceeding 1390 Elo, while ranking second in more complex audio-inclusive benchmarks. The results are notable not only for performance, but because the model is fully open source with commercial licensing, making its capabilities broadly accessible.

The system uses a 15-billion-parameter Transformer architecture designed to generate synchronized audio and video in a single pass. It supports features such as native lip-sync across multiple languages, including Mandarin, English, and Japanese, and can produce 1080p video in under a minute using a single NVIDIA H100 GPU. The full model weights, along with distilled versions and supporting tools, have been released publicly, allowing developers to run the system locally.

HappyHorse-1.0 was developed by an independent research team with roots in Alibaba Group’s former Taotian research unit and led by Zhang Di, previously a senior executive at Kuaishou. The team emphasized a focus on real-world user preference in evaluation, rather than traditional benchmark optimization.

Open Source Gains Ground

The model’s success highlights a broader shift in the AI industry, where open-source systems are increasingly competitive with proprietary offerings. Historically, leading performance in areas like video generation has been dominated by closed models developed by large technology companies. HappyHorse-1.0 suggests that smaller, independent teams can now rival or exceed those capabilities.

This dynamic mirrors trends seen in other areas of AI, including language models and image generation, where open ecosystems have accelerated innovation and lowered barriers to entry. By releasing full model weights and tools, the developers are enabling rapid experimentation and customization across industries.

Implications for the AI Video Market

The emergence of a high-performing open-source video model could intensify competition among AI providers, particularly in creative and media applications. Lower-cost access to advanced video generation may benefit startups and developers, while putting pressure on proprietary platforms to differentiate through features, integration, or performance.

At the same time, the availability of powerful video generation tools raises questions around misuse, content authenticity, and regulation. As capabilities improve, ensuring responsible deployment will remain a key challenge for both developers and policymakers.

HappyHorse-1.0’s rapid rise signals that the balance of power in AI video may be shifting, with open-source innovation playing an increasingly central role in shaping the next phase of the market.

Meta Platforms is developing an AI-powered digital version of CEO Mark Zuckerberg that could interact with employees when he is unavailable, according to reports. The avatar is expected to be trained on Zuckerberg’s voice, appearance, and communication style, marking a new step in Meta’s broader effort to integrate artificial intelligence into both internal operations and consumer-facing products.

The project comes as Meta accelerates its investment in AI, with plans to spend between $115 billion and $135 billion on AI-related infrastructure in 2026 alone. The company has also been aggressively hiring talent for its newly formed Superintelligence Labs, led by Alexandr Wang. The division recently launched Muse Spark, a multimodal AI model designed to compete with leading systems in reasoning and agent-based tasks, with additional models expected later this year.

Meta’s ambitions extend beyond language models. The company is developing photorealistic 3D avatars capable of natural conversation, with the Zuckerberg replica serving as an early test case. If successful, the technology could expand to allow creators and public figures to build AI versions of themselves, potentially opening new forms of digital interaction and content creation.

AI Meets Leadership and Identity

The concept of AI-generated executive avatars reflects a broader trend among technology leaders experimenting with digital replicas. Executives such as Sebastian Siemiatkowski and Eric Yuan have explored similar ideas, using AI versions of themselves for tasks like earnings presentations or meetings. Investor Ray Dalio has also deployed a digital avatar to share his views online.

Meta is reportedly also working on an AI agent tailored for executive use, capable of helping Zuckerberg manage daily tasks such as retrieving information and coordinating decisions. Together, these efforts point to a future where AI tools augment leadership roles rather than simply supporting general productivity.

From Metaverse to AI

The initiative highlights Meta’s strategic pivot away from its earlier focus on the metaverse toward artificial intelligence as its core priority. Avatars were once central to Zuckerberg’s vision for virtual worlds, but early efforts drew criticism for limited realism and failed to gain widespread traction.

Now, advances in AI are enabling more sophisticated and lifelike digital representations, potentially reviving aspects of that vision in a new form. Meta has previously experimented with personality-driven AI chatbots modeled on celebrities, though the company faced backlash over safety concerns, particularly for younger users.

The development of an AI version of Zuckerberg underscores how far the company is willing to push the boundaries of identity and interaction in the AI era. Whether the concept gains traction internally or expands into consumer products may depend on how effectively Meta can balance innovation with user trust and ethical considerations.